EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Pan‐cancer analysis of altered glycosyltransferases confers poor clinical outcomes

Saravanakumar Marimuthu, Surinder K Batra, Moorthy P Ponnusamy

Clinical and Translational Discovery · 2022

DOI: 10.1002/ctd2.100 ↗

At a glance

Journal article in Clinical and Translational Discovery, 2022. Written by Saravanakumar Marimuthu and 2 co-authors. Institution: Department of Biochemistry and Molecular Biology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA. Cited 3 times so far (Crossref); 10 references. The full text is freely available (open access, CC BY 4.0). Funded by: NCI NIH HHS, U.S. Department of Health and Human Services, National Institutes of Health.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Glycosylation is a post-translational modification (PTM) process that attaches carbohydrates to proteins and lipids.Protein glycosylation can be N-linked or O-linked depending on adding sugars onto the side chains of Asn or Ser/Thr residues, respectively.PTM comprises glycanmodifying enzymes glycosyltransferases (GTs) and glycosidases.O-glycan truncation, N-glycan branching, sialylation and fucosylation are the most well-known cancerassociated glycosylations.The glycan-modifying enzymes stimulate various malignant behaviours of tumours, such as tumour proliferation, invasion, epithelial-mesenchymal transition, metastasis, angiogenesis, immune modulation and cell-matrix interactions.1,2 Over 200 GTs regulate glycosylation.An unbiased global approach must be used to identify glycogenes in cancer.In this study,

Subjects

Author keywords

GlycosylationGlycosyltransferasesMetastasisTumorigenesis

Authors and institutions

  • Department of Biochemistry and Molecular Biology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
  • Eppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.
  • Department of Pathology and Microbiology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.

Funding

  • NCI NIH HHS
  • U.S. Department of Health and Human Services
  • National Institutes of Health
  • National Cancer Institute

Cite

APA

Marimuthu, S., Batra, S. K., & Ponnusamy, M. P. (2022). Pan‐cancer analysis of altered glycosyltransferases confers poor clinical outcomes. Clinical and Translational Discovery. https://doi.org/10.1002/ctd2.100

Vancouver

Marimuthu S, Batra SK, Ponnusamy MP. Pan‐cancer analysis of altered glycosyltransferases confers poor clinical outcomes. Clinical and Translational Discovery. 2022. doi:10.1002/ctd2.100

BibTeX
@article{Marimuthu2022,
  author = {Marimuthu, Saravanakumar and Batra, Surinder K and Ponnusamy, Moorthy P},
  title = {Pan‐cancer analysis of altered glycosyltransferases confers poor clinical outcomes},
  journal = {Clinical and Translational Discovery},
  year = {2022},
  doi = {10.1002/ctd2.100}
}
Start for free →